Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

ReShape Lifesciences, Inc. - Common Stock (NQ:RSLS)

6.840 +2.530 (+58.70%)
Streaming Delayed Price Updated: 1:24 PM EDT, Jun 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about ReShape Lifesciences, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Why ReShape Lifesciences Stock Is Soaring Today: Key Drivers Behind Weight-Loss Company's Surge
ReShape Lifesciences gains MDR and UKCA certification for all EU and UK devices, meeting strict regulatory standards well before the 2027 deadline. 
Via Benzinga
Which stocks are moving on Tuesday?
Here are the top movers in Tuesday's session, showcasing the stocks with significant price changes. 
Via Chartmill
ReShape Lifesciences Stock Soars On Regulatory Certification For Medical Devices In EU, UK: Retail Eyes Fair Valuation
ReShape CEO Paul F. Hickey said that the company achieved MDR and UKCA certification “well in advance” of the Dec. 31, 2027, regulatory deadline. 
Via Stocktwits
Tuesday's session: gap up and gap down stocks
There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Tuesday. 
Via Chartmill
ReShape Lifesciences® Announces EU MDR Certification for Entire European and United Kingdom Product Portfolio
From ReShape Lifesciences Inc
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Why Blueprint Medicines Shares Are Trading Higher By 27%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Friday's after hours session: top gainers and losers
After the closing bell on Friday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session. 
Via Chartmill
ReShape Lifesciences® Reports First Quarter Ended March 31, 2025 Financial Results and Provides Corporate Update
Merger Agreement With Vyome Therapeutics and Asset Purchase Agreement with Biorad Medisys Progress Towards Completion 
From ReShape Lifesciences Inc
Via GlobeNewswire
Orla Mining, ReShape Lifesciences And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Via Benzinga
Why Sable Offshore Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket
Via Benzinga
ReShape Lifesciences Announces 1-for-25 Reverse Stock Split
Effective as of Commencement of Trading on May 9, 2025 
From ReShape Lifesciences Inc
Via GlobeNewswire
Stocktwits Spotlight: NRx, CVS, ReShape Lead Weekly Jump In Health Care Stock Chatter
Favorable regulatory moves for a new drug application, blowout earnings and promising preclinical data triggered a flurry of discussions on Stocktwits for these tickers for the week ended April 11,... 
Via Stocktwits
Topics Intellectual Property Law Enforcement Lawsuit
Exposures Financial Intellectual Property Legal
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
EXCLUSIVE: April's 20 Most-Searched Tickers On Benzinga Pro — Where Do Tesla, Apple, Palantir, Nvidia Stocks Rank?
Each trading day features hundreds of headlines and press releases on Benzinga Pro, a source for traders to see the latest news on the overall market and individual tickers. 
Via Benzinga
ReShape Lifesciences® Presents Pre-clinical Data on Its Proprietary Diabetes Neuromodulation Device at the 12th Annual Minnesota Neuromodulation Symposium
From ReShape Lifesciences Inc
Via GlobeNewswire
ReShape Lifesciences® Receives Notice of Allowance for Key U.S. Patent Related to an Intragastric Balloon System
Patent Expands and Strengthens Intellectual Property Portfolio Around a Swallowable and Degradable Intragastric Device 
From ReShape Lifesciences Inc
Via GlobeNewswire
ReShape Lifesciences Ignites Retail Frenzy As Stock Soars On US Patent For Diabetes Neuromodulation System
The technology leverages ReShape’s proprietary vagus nerve block and stimulation platform to regulate blood glucose in patients with Type 2 diabetes by modulating nerve signals to the liver and... 
Via Stocktwits
Topics Intellectual Property
Exposures Intellectual Property
Here are the top movers in Monday's session.
Keep an eye on the top gainers and losers in Monday's session, as they reflect the most notable price movements. 
Via Chartmill
Most active stocks in Monday's session
Stay updated with the latest market activity on Monday. Explore the most active stocks in today's session and stay informed about the stocks that are in the spotlight. 
Via Chartmill
Top movers analysis in the middle of the day on 2025-04-21: top gainers and losers in today's session.
Looking for insights into the US markets in the middle of the day on Monday? Delve into the top gainers and losers of today's session and gain valuable market intelligence. 
Via Chartmill
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
The market is filled with gapping stocks in Monday's session.
The market is filled with gapping stocks in Monday's session. Let's discover which stocks are showing gap-ups and gap-downs. 
Via Chartmill
ReShape Lifesciences® Receives Notice of Allowance for Additional U.S. Patent Related to Its Proprietary Diabetes Neuromodulation Technology
From ReShape Lifesciences Inc
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Top stock movements in today's session.
Stay up-to-date with the latest market trends one hour before the close of the markets on Thursday. Explore the top gainers and losers during today's session in our detailed report. 
Via Chartmill
Most active stocks in Thursday's session
Let's have a look at what is happening on the US markets on Thursday. Below you can find the most active stocks in today's session. 
Via Chartmill
< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.